Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,432.97
(
1.08%
)
US TECH 100
28,330.00
(
0.96%
)
Dow Jones
50,009.35
(
1.31%
)
Brent Oil
102.83
(
0.53%
)
Bitcoin
77,964.75
(
0.62%
)
News Focus
News Focus
Post# of 257591
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: Rocky3 post# 150405

Thursday, 10/11/2012 4:56:35 AM

Thursday, October 11, 2012 4:56:35 AM

Post# of 257591
Thanks for that post.
Seems that there's a consensus regarding BG-12 becoming the biggest drug in MS in time. Aubagio doesn't look like a great choice considering its limited efficacy and tox and certainly not a 1st line drug. Alemtuzumab's safety issues will very much limit its use.
No mention of Gilenya just next gen S1P1 compounds?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today